GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurocrine Biosciences Inc (BSP:N1BI34) » Definitions » Investments And Advances

Neurocrine Biosciences (BSP:N1BI34) Investments And Advances : R$5,237 Mil (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Neurocrine Biosciences Investments And Advances?

Neurocrine Biosciences's Investments And Advances for the quarter that ended in Mar. 2025 was R$5,237 Mil.

Neurocrine Biosciences's quarterly Investments And Advances increased from Sep. 2024 (R$4,267 Mil) to Dec. 2024 (R$5,273 Mil) but then declined from Dec. 2024 (R$5,273 Mil) to Mar. 2025 (R$5,237 Mil).

Neurocrine Biosciences's annual Investments And Advances increased from Dec. 2022 (R$2,106 Mil) to Dec. 2023 (R$4,162 Mil) and increased from Dec. 2023 (R$4,162 Mil) to Dec. 2024 (R$5,273 Mil).


Neurocrine Biosciences Investments And Advances Historical Data

The historical data trend for Neurocrine Biosciences's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurocrine Biosciences Investments And Advances Chart

Neurocrine Biosciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,364.89 3,530.92 2,106.03 4,161.89 5,273.09

Neurocrine Biosciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,302.05 4,208.70 4,267.43 5,273.09 5,236.99

Neurocrine Biosciences Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Neurocrine Biosciences Business Description

Traded in Other Exchanges
Address
6027 Edgewood Bend Court, San Diego, CA, USA, 92130
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Neurocrine Biosciences Headlines

No Headlines